Abstract
This study aimed at evaluating the extent of benzodiazepine (BZD) consumption among nursing home residents and examining additional mental health problems. Urine samples were collected in nursing homes in a border region between Austria and Germany and analyzed for BZD using a liquid chromatographic-tandem mass spectrometric method (LC–MS/MS). In addition, a questionnaire was applied to the residents including the ICD-10 symptom rating scale; nursing staff filled out a further questionnaire on residents’ consumption of addictive drugs. Of 301 urine samples collected in 33 nursing homes, 103 (34.2%) were BZD positive. BZD users showed significantly higher values for depression and anxiety. Nursing staff reported consumption of addictive drugs in 29 (37.2% of BZD positives) with almost entirely BZD use. In nearly 4% of BZD users, nursing staff indicated drug abuse/dependence. BZD use appears to be rather common in nursing homes and nurses apparently do not recognize the addictive potential of BZD sufficiently. Interventions should aim at a reduction of BZD prescriptions by sensitizing primary care physicians and nursing staff.
Similar content being viewed by others
References
Aebi, C. (2002). Validierung der neuropsychologischen Testbatterie CERAD-NP: eine Multi-Center Studie. Retrieved October 07, 2021, from https://www.memoryclinic.ch/fileadmin/user_upload/Memory_Clinic/Literatur/2002/Aebi_2002.pdf
Alvim, M. M., Da Cruz, D. T., Vieira, Md. T., Bastos, R. R., & Leite, I. C. G. (2017). Prevalence of and factors associated with benzodiazepine use in community-resident elderly persons. Revista Brasileira de Geriatria e Gerontologia, 20(4), 463–473.
American Geriatrics Society Beers Criteria® Update Expert Panel, Fick, D. M., Semla, T. P., Steinman, M., Beizer, J., Brandt, N., et al. (2019). American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694.
Assem-Hilger, E., Jungwirth, S., Weissgram, S., Kirchmeyr, W., Fischer, P., & Barnas, C. (2009). Benzodiazepine use in the elderly: An indicator for inappropriately treated geriatric depression? International Journal of Geriatric Psychiatry, 24(6), 563–569.
Azermai, M., Elseviers, M., Petrovic, M., van Bortel, L., & Stichele, R. V. (2011). Geriatric drug utilisation of psychotropics in Belgian nursing homes. Human Psychopharmacology: Clinical and Experimental, 26(1), 12–20.
Bartlett, G., Abrahamowicz, M., Grad, R., Sylvestre, M.-P., & Tamblyn, R. (2009). Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons. BMC Family Practice, 10(1), 1.
Bell, J. S., Lavikainen, P., Korhonen, M., & Hartikainen, S. (2010). Benzodiazepine discontinuation among community-dwelling older people: A population-based cohort study. European Journal of Clinical Pharmacology, 67(1), 105–106.
Bogunovic, O. J., & Greenfield, S. F. (2004). Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatric Services (Washington, D.C.), 55(3), 233–235.
Bourgeois, J., Elseviers, M. M., van Bortel, L., Petrovic, M., & Vander Stichele, R. H. (2013). Sleep quality of benzodiazepine users in nursing homes: A comparative study with nonusers. Sleep Medicine, 14(7), 614–621.
Cook, J. M., Marshall, R., Masci, C., & Coyne, J. C. (2007). Physicians’ perspectives on prescribing benzodiazepines for older adults: A qualitative study. Journal of General Internal Medicine, 22(3), 303–307.
Cumming, R. G., & Le Conteur, D. G. (2003). Benzodiazepines and risk of hip fractures in older people. CNS Drugs, 17(11), 825–837.
Díaz-Gutiérrez, M. J., Martínez-Cengotitabengoa, M., de Adana, E. S., Cano, A. I., Martínez-Cengotitabengoa, M. T., Besga, A., et al. (2017). Relationship between the use of benzodiazepines and falls in older adults: A systematic review. Maturitas, 101, 17–22.
Dou, C., Rebane, J., & Bardal, S. (2019). Interventions to improve benzodiazepine tapering success in the elderly: A systematic review. Aging & Mental Health, 23(4), 411–416.
Du, Y., Scheidt-Nave, C., & Knopf, H. (2008). Use of psychotropic drugs and alcohol among non-institutionalised elderly adults in Germany. Pharmacopsychiatry, 41(06), 242–251.
Evrard, P., Henrard, S., Foulon, V., & Spinewine, A. (2020). Benzodiazepine use and deprescribing in belgian nursing homes: Results from the COME-ON Study. Journal of the American Geriatrics Society, 68(12), 2768–2777.
Fourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001). Benzodiazepine use in an elderly community-dwelling population. European Journal of Clinical Pharmacology, 57(5), 419–425.
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. BMJ, 331(7526), 1169.
Gupta, A., Bhattacharya, G., Balaram, K., Tampi, D., & Tampi, R. R. (2021). Benzodiazepine use among older adults: Future Medicine.
Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian journal of statistics, 65–70.
Jorm, A. F., Grayson, D., Creasey, H., Waite, L., & Broe, G. A. (2000). Long-term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health, 24(1), 7–10.
Lader, M. (2011). Benzodiazepines revisited–Will we ever learn? Addiction (Abingdon, England), 106(12), 2086–2109.
Linden, M., Bär, T., & Helmchen, H. (2004). Prevalence and appropriateness of psychotropic drug use in old age: Results from the Berlin Aging Study (BASE). International Psychogeriatrics, 16(4), 461–480.
Liu, L., Jia, L., Jian, P., Zhou, Y., Zhou, J., Wu, F., & Tang, Y. (2020). The Effects of benzodiazepine use and abuse on cognition in the elders: A systematic review and meta-analysis of comparative studies. Frontiers in Psychiatry, 11, 755.
Mann, E., Böhmdorfer, B., Frühwald, T., Roller-Wirnsberger, R. E., Dovjak, P., Dückelmann-Hofer, C., et al. (2012). Potentially inappropriate medication in geriatric patients: The Austrian consensus panel list. Wiener Klinische Wochenschrift, 124(5–6), 160–169.
Mathieu, C., Joly, P., Jacqmin-Gadda, H., Wanneveich, M., Bégaud, B., & Pariente, A. (2020). Patterns of benzodiazepine use and excess risk of all-cause mortality in the elderly: A nationwide cohort study. Drug Safety, 1–10.
Moosmann, B., Hutter, M., Huppertz, L. M., Ferlaino, S., Redlingshöfer, L., & Auwärter, V. (2013). Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicology, 31(2), 263–271.
Mura, T., Proust-Lima, C., Akbaraly, T., Amieva, H., Tzourio, C., Chevassus, H., et al. (2013). Chronic use of benzodiazepines and latent cognitive decline in the elderly: Results from the Three-city study. European Neuropsychopharmacology, 23(3), 212–223.
Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72(2), 136–142.
Peters, F., Hartung, M., Herbold, M., SchmittDaldrup, G. T., & Mußhoff, F. (2009). Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech, 76(3), 185–208.
Picton, J. D., Marino, A. B., & Nealy, K. L. (2018). Benzodiazepine use and cognitive decline in the elderly. American Journal of Health-System Pharmacy, 75(1), e6–e12. Retrieved September 29, 2021.
Poly, T. N., Islam, M. M., Yang, H.-C., & Li, Y.-C.J. (2020). Association between benzodiazepines use and risk of hip fracture in the elderly people: A meta-analysis of observational studies. Joint, Bone, Spine, 87(3), 241–249.
Ray, W. A., Thapa, P. B., & Gideon, P. (2000). Benzodiazepines and the risk of falls in nursing home residents. Journal of the American Geriatrics Society, 48(6), 682–685.
Richter, T., Mann, E., Meyer, G., Haastert, B., & Köpke, S. (2012). Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts. Journal of the American Medical Directors Association, 13(2), 187. e7-187. e13.
Snowdon, J., Vaughan, R., Miller, R., Burgess, E. E., & Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163(2), 70–72.
Stevenson, D. G., Decker, S. L., Dwyer, L. L., Huskamp, H. A., Grabowski, D. C., Metzger, E. D., & Mitchell, S. L. (2010). Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 National Nursing Home Survey. The American Journal of Geriatric Psychiatry, 18(12), 1078–1092.
Taylor, S., McCracken, C. F., Wilson, K. C., & Copeland, J. R. (1998). Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. The British Journal of Psychiatry: The Journal of Mental Science, 173, 433–438.
Tritt, K., von Heymann, F., Zaudig, M., Zacharias, I., Söllner, W., & Loew, T. (2008). Development of the “ICD-10-Symptom-Rating” (ISR) questionnaire. Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie, 54(4), 409–418.
Tsunoda, K., Uchida, H., Suzuki, T., Watanabe, K., Yamashima, T., & Kashima, H. (2010). Effects of discontinuing benzodiazepine-Derivative hypnotics on postural sway and cognitive functions in the elderly. International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 25(12), 1259–1265.
van Dijk, K. N., de Vries, C. S., van den Berg, P. B., Brouwers, J. J., & de Jong-van den Berg, L. T. (2000). Drug utilisation in Dutch nursing homes. European Journal of Clinical Pharmacology, 55(10), 765–771.
van Vliet, P., van der Mast, R. C., van den Broek, M., Westendorp, R. G. J., & de Craen, A. J. M. (2009). Use of benzodiazepines, depressive symptoms and cognitive function in old age. International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 24(5), 500–508.
Wu, C.-S., Wang, S.-C., Chang, I.-S., & Lin, K.-M. (2009). The association between dementia and long-term use of benzodiazepine in the elderly: Nested case–control study using claims data. The American Journal of Geriatric Psychiatry, 17(7), 614–620.
Acknowledgements
We would also like to thank the staff and residents of all nursing homes for their participation in this project.
Funding
The authors gratefully acknowledge the funding provided by the European Regional Development Fund (Europäischer Fonds für regionale Entwicklung – EFRE). Furthermore, the Bavarian State Ministry of the Environment and Public Health, the Caritas Bad Reichenhall, and the Salzburg State Hospital provided financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dreher-Weber, M., Laireiter, AR., Kühberger, A. et al. Assessment of Benzodiazepine (BZD) Use Among Nursing Home Residents by Liquid Chromatography-Tandem Mass Spectrometry, Nursing Questionnaires, and Examining Additional Mental Health Problems of BZD Users. Int J Ment Health Addiction 21, 1713–1726 (2023). https://doi.org/10.1007/s11469-021-00685-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-021-00685-x